Showing results (1941-1950 of 8,425) with videos related to

Sort By:
Pageof 843
Clinical Neuropharmacology|November 11, 2006
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosisDoron Merims, Meirav Balas, Chava Peretz, et al.
Journal of Child Language|November 14, 2008
Prosodic patterns in Hebrew child-directed speechOsnat Segal, Bracha Nir-Sagiv, Liat Kishon-Rabin, et al.
Bioinformatics (Oxford, England)|June 10, 2010
Modularity and directionality in genetic interaction mapsAriel Jaimovich, Ruty Rinott, Maya Schuldiner, et al.
Archives of Physical Medicine and Rehabilitation|May 2, 2009
Self-report of missteps in older adults: a valid proxy of fall risk?Jennifer M Srygley, Talia Herman, Nir Giladi, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 27, 2006
The effect of information level and coping style on pain and anxiety in needle liver biopsyNir Hilzenrat, Rose Yesovitch, Ian Shrier, et al.
Journal of the Science of Food and Agriculture|June 24, 2010
Effect of nitrogen source in the fertilizing solution on nutritional quality of three members of the Portulaca oleracea aggregateGabriella Szalai, Nir Dai, Avinoam Danin, et al.
Journal of Healthcare Management / American College of Healthcare Executives|June 23, 2010
Hospital IT adoption strategies associated with implementation success: implications for achieving meaningful useEric W Ford, Nir Menachemi, Timothy R Huerta, et al.
Archives of Physical Medicine and Rehabilitation|August 19, 2011
A training program to improve gait while dual tasking in patients with Parkinson's disease: a pilot studyGalit Yogev-Seligmann, Nir Giladi, Marina Brozgol, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancerNir Peled, Koichi Yoshida, Murry W Wynes, et al.
Therapeutics and Clinical Risk Management|August 17, 2011
Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawalPatrick Lemoine, Doron Garfinkel, Moshe Laudon, et al.
Pageof 843